AngioDynamics Inc. reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2015. For the quarter, the company's net sales were $89,234,000 against $92,149,000 a year ago. Operating income was $1,317,000 against $4,575,000 a year ago. Loss before income taxes was $728,000 against income before income taxes of $2,829,000 a year ago. Net loss was $362,000 against net profit of $1,338,000 a year ago. Loss per basic and diluted share was $0.01 against earnings per share basic and diluted of $0.04 a year ago. Adjusted net income was $5,058,000 against $6,229,000 a year ago. Adjusted diluted earnings per share were $0.14 against $0.17 a year ago. EBITDA was $8,395,000 against $11,874,000 a year ago. Adjusted EBITDA was $13,400,000 against $15,924,000 a year ago. EBITDA per diluted share was $0.23 against $0.33 a year ago. Adjusted EBITDA was $0.37 against $0.44 a year ago. Net cash provided by operating activities was $9,579,000 against net cash used in operating activities of $2,147,000 a year ago. Additions to property, plant and equipment was $425,000 against profit of $2,419,000 a year ago.

For the six months, the company's net sales were $172,937,000 against $179,480,000 a year ago. Operating income was $2,387,000 against $7,817,000 a year ago. Loss before income taxes was $1,402,000 against income before income taxes of $4,247,000 a year ago. Net loss was $1,119,000 against net profit of $1,808,000 a year ago. Loss per basic and diluted share was $0.03 against earnings per share basic and diluted of $0.05 a year ago. Adjusted net income was $9,034,000 against $11,879,000 a year ago. Adjusted diluted earnings per share were $0.25 against $0.33 a year ago. EBITDA was $16,569,000 against $21,816,000 a year ago. Adjusted EBITDA was $25,294,000 against $30,351,000 a year ago. EBITDA per diluted share was $0.45 against $0.61 a year ago. Adjusted EBITDA was $0.69 against $0.84 a year ago. Net cash provided by operating activities was $14,278,000 against $3,205,000 a year ago. Additions to property, plant and equipment was $1,168,000 against profit of $7,523,000 a year ago.

The company revised its fiscal 2016 net sales guidance of $353 million to $359 million and adjusted earnings per share (EPS) of $0.59 to $0.63. The company expects maintenance CapEx between $6 million to $8 million. The company expects CapEx between $4 million to $6 million.

The company expects fiscal 2016 third quarter net sales to be in the range of $84 to $87 million and adjusted EPS of $0.10 to $0.14.